´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø(2023-2030³â)
Single Photon Emission Computed Tomography (SPECT) Market, By Product Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
»óǰÄÚµå : 1373911
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2023³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 286 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,544,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,502,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,900,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀå ±Ô¸ð´Â 2022³â 18¾ï 920¸¸ ´Þ·¯¿¡ À̸£·¶À¸¸ç, 2023³âºÎÅÍ 2030³â±îÁö CAGR 9.2%ÀÇ È®´ë°¡ ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ(SPECT) ½ÃÀå-½ÃÀå ¿ªÇÐ

¾Ï ÀÌȯÀ² »ó½ÂÀ¸·Î ½ÃÀå ¼ö¿ä ÃËÁø

¼¼°èÀÇ ¹æ»ç¼º ÀǾàǰ »ê¾÷ÀÇ °³Ã´Àº SPECT ½ÃÀå ÀüüÀÇ ÇöÀúÇÑ ¼ºÀåÀ» º¸¿©ÁÝ´Ï´Ù. ¾Ï Áø´Ü¿¡¼­´Â SPECT ½ºÄ³³Ê°¡ ³Î¸® »ç¿ëµÇ°í ÀÖÀ¸¸ç, ¾ÏÀ̳ª ½ÉÇ÷°ü Áúȯ°ú °°Àº ´Ù¾çÇÑ °Ç°­ »óÅÂÀÇ ÀÌȯÀ² »ó½ÂÀÌ ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹Þħ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º¸´Ù ½Å¼ÓÇÑ Áø´Ü°ú Ä¡·á¸¦ À§ÇØ Ã·´Ü À̹Ì¡ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â °ÍÀº ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î º¸ÀÔ´Ï´Ù. Áø´Ü ¿ëµµ¿¡ À־ÀÇ ±â¼úÀÇ Áøº¸°¡ ½ÃÀå ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ SPECT ½ºÄ³³Ê°¡ Á¦°øÇÏ´Â ±â¼ú, ¹®Á¦ Ç¥ÇöÇü, ÇØºÎÇÐÀû À̹ÌÁöÀÇ °­·ÂÇÑ º¹ÇÕÀû ÀÌÁ¡Àº ¸ÅÃâÀ» µÞ¹ÞħÇϰí SPECT ½ÃÀå ¼ö¿ä Áõ°¡¸¦ °¡Á®¿É´Ï´Ù. ±×·¯³ª ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·ÀÌ ½ÃÀå ¼ºÀåÀÇ ¾ïÁ¦¿äÀÎÀÌ µÉ °Í °°½À´Ï´Ù. °Ô´Ù°¡ ½ºÆ®·¹½º, ½Ä»ýȰ ±³¶õ, ¶óÀÌÇÁ½ºÅ¸ÀÏ º¯È­·Î ÀÎÇÑ Áúº´ À¯º´·ü Áõ°¡´Â ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ÇÁ·Îºê ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ¹Ð¾î¿Ã¸± °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ(SPECT) ½ÃÀå-ÁÖ¿ä ÀλçÀÌÆ®·Â

´ç»çÀÇ ¿¬±¸ ºÐ¼®°¡°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é ¼¼°èÀÇ ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030³â)¿¡ ¾à 9.2%ÀÇ CAGR·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) »ê¾÷Àº ¾Ï ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÇöÀúÇÑ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÊ

Á¦Ç° À¯Çüº°·Î´Â ´Üü SPECT°¡ 2022³â ÃÖ´ë ½ÃÀå Á¡À¯À²À» ³ªÅ¸³ÂÀ½p>

¿ëµµº°·Î´Â 2022³â¿¡ ¼øÈ¯±â ³»°ú°¡ ÁÖ¿ä À¯ÇüÀ̾ú½À´Ï´Ù.

SPECTÀÇ »ç¿ë¿¡ ´ëÇÑ ÀÎÁöµµ Áõ°¡¿Í ÀüÀÓ»ó À̹Ì¡ÀÇ »ç¿ë°ú °ü·ÃµÈ ÀÌÁ¡¿¡ ´ëÇÑ È¯ÀÚ¿Í ÀÇ»çÀÇ ÀǽÄÀº SPECT ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÀÚ±ØÇÏ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ(SPECT) ½ÃÀå-¼¼ºÐÈ­ ºÐ¼® :

¼¼°èÀÇ ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀåÀº Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

Á¦Ç° À¯Çü¿¡ µû¶ó ½ÃÀåÀº ÇÏÀ̺긮µå SPECT ½Ã½ºÅÛ°ú µ¶¸³Çü SPECT ½Ã½ºÅÛÀÇ µÎ °¡Áö·Î ºÐ·ùµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È µ¶¸³Çü SPECT ºÐ¾ß°¡ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ºÎ¹®Àº ½ÉÀå ºÎ¹®°ú ¾Ï ºÎ¹®¿¡¼­ µ¶¸³Çü SPECTÀÇ »ç¿ëÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. µ¶¸³Çü SPECTÀÇ ÀÏÁ¾Àº °¨¸¶¼±À» ÀÌ¿ëÇÑ ÇÙ ¾à¹° À̹Ì¡ ÀåÄ¡ÀÔ´Ï´Ù. ÀÌ¿¡ µû¶ó Áø´Ü ¹× Áúº´ °ü¸®¸¦ À§ÇÑ À̹ÌÁö¸¦ Á¦°øÇϱâ À§ÇØ, ÀÌ ÀåÄ¡´Â ½Ç½Ã°£À¸·Î °íǰÁúÀÇ Àü½Å ´ÜÃþ »çÁøÀ» »ý¼ºÇϰí ÁÖÀÔµÈ ¹æ»ç¼º µ¿À§¿ø¼Ò·ÎºÎÅÍÀÇ °¨¸¶¼± ¹æÃâÀ» ºÐ¼®ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀº ¿ëµµº°·Î ½Å°æÇÐ, ¼øÈ¯±âÇÐ, Á¾¾çÇÐ, ÀÏ¹Ý ¿µ»ó Áø´Ü, ±âŸ ³× °¡Áö ¹üÁÖ·Î ºÐ·ùµË´Ï´Ù. °¡Àå Å« ÆÇ¸Å Á¡À¯À²À» Â÷ÁöÇÏ´Â °ÍÀº ¼øÈ¯±â ³»°úÀÔ´Ï´Ù. °ü»ó µ¿¸Æ Áúȯ ¹× ±âŸ ½ÉÀå °ü·Ã Áúȯ ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼¼°è ¼øÈ¯±â°ú¿¡¼­ SPECT ½ºÄ³³Ê¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. SPECT ½ºÄ³³Ê´Â ½ÉÀå Àü¹®Àǰ¡ Ç÷°ü ³»ÀÇ Ç÷·ù¸¦ È®ÀÎÇÏ°í ¹ß»ýÇÑ ½ÉÀå ¹®Á¦¸¦ Á¤È®ÇÏ°Ô °¨ÁöÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀº °¨¸¶ Ä«¸Þ¶ó·Î ¹æ»ç¼º Æ®·¹À̼­¸¦ ÁÖÀÔÇÏ¿© Áø´ÜÇϰųª È®ÀÎÇÕ´Ï´Ù.

´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀå-Áö¸®Àû ÀλçÀÌÆ®

Áö¸®ÀûÀ¸·Î ºÏ¹Ì´Â ¼¼°è ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì¿¡¼­ ½ÃÀå ¼ºÀåÀÇ ¿äÀÎÀº °Ç°­ °ü¸® ºÎ¹®¿¡ ÀÇÇÑ ¼±Áø À̹Ì¡ ±â¼úÀÇ ±Þ¼ÓÇÑ Ã¤¿ëÀÔ´Ï´Ù. ÃÖ±Ù, ½ÉÇ÷°ü Àå¾Ö³ª ¾ÏÀÇ Áõ·Ê°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ, È¿°úÀûÀÎ ºÐÀÚ À̹Ì¡ SPECT ½ºÄ³³Ê ¼ö¿ä¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹°ú ij³ª´Ù´Â ¹æ»ç¼º ÀǾàǰ°ú È®¸³µÈ ÇコÄÉ¾î »ê¾÷ÀÇ Á¸Àç·Î ½ÃÀå ¼ºÀå¿¡ °¡Àå Å« °øÇå±¹À¸·Î º¸ÀÔ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº °Ç°­ °ü¸® »ê¾÷ÀÇ ÁöÃâ Áõ°¡·Î ¼¼°èÀÇ ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ ½ÃÀå¿¡¼­ °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀ¸·Î ¿¹ÃøµË´Ï´Ù.

´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀå-°æÀï ±¸µµ :

ÀÓ»ó½ÃÇè Áõ°¡, ¿¬±¸°³¹ßºñ, Àü·«Àû ÆÄÆ®³Ê½Ê, ½ÃÀå ±â¾÷ °£ Çù·Â, º¹ÇÕ¸ð´Þ¸®Æ¼ SPECT ½Ã½ºÅÛ ¹ß¸í, Á¦Ç° Æ÷Æ®Æú¸®¿À È®´ë µîÀÇ ¿äÀÎÀÌ ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ¹ý ¼¼°è ½ÃÀå ¼ºÀåÀ» µÞ¹Þħ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸î °¡Áö À¯¸®ÇÑ Á¤ºÎ Á¤Ã¥, ÀÇ·áºñ Áõ°¡, °Ç°­ °ü¸® ºÐ¾ß¿¡¼­ Çõ½ÅÀûÀÎ SPECT ½ºÄ³³Ê Ȱ¿ë ¹× ¹ß°ß Áö¿ø, º¸´Ù ½±°í ºü¸¥ Áúº´ Áø´ÜÀ» À§ÇÑ Áø´Ü¼¾ÅÍ Áõ°¡ µî ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ¿äÀÎÀÌ µÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 3¿ù NorthStar Medical Radioisotopes, LLC´Â °¡Àå ³Î¸® »ç¿ëµÇ´Â ÀÇ·á¿ë ¹æ»ç¼º µ¿À§ ¿ø¼ÒÀÎ Å×Å©³×Ƭ-99m(Tc-99m)ÀÇ °¡¿ë¼ºÀ» ¼¼°èÀûÀ¸·Î °­È­Çϱâ À§ÇÑ Çù·ÂÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Á¦ÈÞ¸¦ ÅëÇØ ¹Ì±¹ ÀÌ¿ÜÀÇ ±â¾÷Àº IBAÀÇ ºö¶óÀΰú °¡¼Ó±â¸¦ »ç¿ëÇÏ¿© Á¦Á¶µÈ ³ë½º½ºÅ¸ °íÀ¯ÀÇ ºñ¿ì¶ó´½ ±â¹Ý Mo-99¸¦ »ç¿ëÇÏ´Â TC-99 m Á¦³Ê·¹ÀÌ¼Ç ½Ã½ºÅÛ(TCM Á¦³Ê·¹ÀÌ¼Ç ½Ã½ºÅÛ)¿¡ Á¢±Ù ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT)ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ¾÷°è Á¶»ç

Á¦5Àå ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀå »óȲ

Á¦7Àå ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀå-Á¦Ç° À¯Çüº°

Á¦8Àå ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀå-¿ëµµº°

Á¦9Àå ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀå-ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå ´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ½ÃÀå-Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼®-´ÜÀÏ ±¤ÀÚ ¹æÃâ ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(SPECT) ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Single photon emission computed tomography (SPECT) market size was valued at USD 1,809.2 Million in 2022, expanding at a CAGR of 9.2% from 2023 to 2030.

Single-photon emission computed tomography (SPECT) test is utilized in preclinical applications to identify the blood flow in the body. The technique also assists in diagnosing disorders/diseases with the aid of imaging. SPECT makes use of short-lived radioisotopes to offer 3D activity of blood flow in the body. It also enables the tracking of their functions and provides imaging of internal organs in the human body. Additionally, in the process of imaging SPECT technology uses gamma cameras and radioactive substances.

Single Photon Emission Computed Tomography (SPECT) Market- Market Dynamics

The rising incidence of cancer is propelling the market demand

The development in the global radiopharmaceutical industry is witnessing significant growth in the overall SPECT market. In the diagnosis of cancer, SPECT scanners are widely used, thus the rising incidence of cancer or different health conditions like cardiovascular diseases is boosting the growth of the single-photon emission computed tomography (SPECT) market. Additionally, for faster diagnosis and treatment purposes the increasing demand for advanced imaging techniques is considered as another major driving factor for the growth of the market. Advancement of technology in diagnostic applications is leading to drive the market demand. Moreover, a powerful combined benefit of the technology, issue phenotyping, and anatomical imaging provided by SPECT scanners, which fuel sales, are resulting in the increasing demand for the SPECT market. However, the lack of skilled professionals is likely to be the restraining factor for the growth of the market. Furthermore, the increasing prevalence of diseases due to stress, poor eating habits, and changing lifestyles is further anticipated to boost the growth of the single photon emission computerized tomography (SPECT) probes market.

Single Photon Emission Computed Tomography (SPECT) Market- Key Insights

As per the analysis shared by our research analyst, the global single photon emission computed tomography (SPECT) market is estimated to grow annually at a CAGR of around 9.2% over the forecast period (2023-2030)

The single photon emission computed tomography (SPECT) industry is projected to grow at a significant rate due to the growing prevalence of cancer disease

Based on product type segmentation, standalone SPECT was predicted to show maximum market share in the year 2022

Based on application segmentation, cardiology was the leading type in 2022

The rising awareness regarding its usage and awareness amongst patients and physicians regarding the advantages associated with the usage of preclinical imaging is further estimated to stimulate the growth of the SPECT market.

Single Photon Emission Computed Tomography (SPECT) Market- Segmentation Analysis:

The global single photon emission computed tomography (SPECT) market is segmented on the basis of product type, application, end user, and region.

The market is divided into two categories based on product type: hybrid SPECT systems and standalone SPECT systems. The standalone SPECT segment is projected to witness the highest growth rate during the forecast period. The segment is attributed to drive by the heart and cancer divisions' rising use of standalone SPECT. A type of standalone SPECT is a nuclear drug imaging device using gamma rays. In line with this, to offer images for diagnosis and disease management, the device can produce high-quality full-body tomographic pictures in real-time and analyze the gamma-ray emissions from an injected radioisotope

The market is divided into four categories based on applications: neurology, cardiology, oncology, general imaging, and others. Cardiology is likely to hold the largest revenue share. The demand for SPECT scanners from cardiology departments across the globe has been boosted by the increasing number of patients with coronary artery diseases and other heart-related diseases. SPECT scanners are used by cardiologists to check blood flow in the vessels and detect the exact heart problem that has occurred. Cardiovascular disease is diagnosed or identified by infusing a radioactive tracer with gamma cameras.

Single Photon Emission Computed Tomography (SPECT) Market- Geographical Insights

Geographically, North America is accounted to dominate the market across the globe. The factor for the growth of the market in North America is the rapid adoption of advanced imaging technology by the healthcare sector. Increasing cases of cardiovascular disorders and cancer in recent years have fueled the demand for effective molecular imaging SPECT scanners. The U.S. and Canada are likely to be considered the largest contributors to the growth of the market due to the presence of radiopharmaceutical and well-established healthcare industries. The Asia Pacific is projected to be the fastest-growing region in the global single-photon emission computed tomography market owing to the growing expenditure in the healthcare industry.

Single Photon Emission Computed Tomography (SPECT) Market- Competitive Landscape:

Factors such as increased clinical trials, R&D spending, strategic partnerships, collaboration between market players, the invention of combined modality SPECT systems, and expansion of product portfolio are propelling the global single-photon emission computed tomography market growth. Additionally, several favorable government policies, an increase in healthcare expenditure, support for the utilization and discovery of innovative SPECT scanners in the healthcare sector, and a rising number of diagnostic centers for easier and faster diagnosis of disease are other factors that contribute to the growth of the market. For instance, in March 2021, NorthStar Medical Radioisotopes, LLC announced a collaboration to increase the availability of technetium-99m (Tc-99m) across the globe, the most widely used medical radioisotope. The collaboration allows companies outside of the U.S. to access the TC-99 m Generation Systems (TCM Generation Systems) that use NorthStar's proprietary non-uranium-based Mo-99 produced using IBA's beamlines and accelerators.

Recent Developments:

For instance, in June 2021, Bayer announced an agreement to acquire Noria Therapeutics Inc. (Noria) and PSMA Therapeutics Inc. Bayer will obtain exclusive rights to a differentiated alpha radionuclide investigational compound based on actinium-225 and a small molecule directed towards prostate-specific membrane antigen (PSMA), through this acquisition.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET KEY PLAYERS

GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY PRODUCT TYPE

GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION

GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY END USER

GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY REGION

Table of Contents

1. Single Photon Emission Computed Tomography (SPECT) Market Overview

2. Executive Summary

3. Single Photon Emission Computed Tomography (SPECT) Key Market Trends

4. Single Photon Emission Computed Tomography (SPECT) Industry Study

5. Single Photon Emission Computed Tomography (SPECT) Market: COVID-19 Impact Analysis

6. Single Photon Emission Computed Tomography (SPECT) Market Landscape

7. Single Photon Emission Computed Tomography (SPECT) Market - By Product Type

8. Single Photon Emission Computed Tomography (SPECT) Market - By Application

9. Single Photon Emission Computed Tomography (SPECT) Market - By End User

10. Single Photon Emission Computed Tomography (SPECT) Market- By Geography

11. Key Vendor Analysis- Single Photon Emission Computed Tomography (SPECT) Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â